Colin A Flaveny

Years Active: 2017-2021
Publications (10 Years): 4

Saint Louis University School of Medicine

Pennsylvania State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Saint Louis University School of Medicine Jul 01 2014

United States

Assistant Professor :: Pharmacology and Physiology

Education History

Pennsylvania State University Jun 01 2004 - May 01 2010

United States

PHD :: Center of Molecular Toxicology Huck Institute of Life Sciences

Publications

Monideepa Sengupta, Suomia Abuirqeba, Amina Kameric, Aurore Cecile-Valfort, Arindam Chatterjee, Kristine Griffett, Thomas P Burris, Colin A Flaveny
A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis. PloS one 16 (3) (2021)
Ryan D Welch, Cyrielle Billon, Amina Kameric, Thomas P Burris, Colin A Flaveny
Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice. PloS one 15 (5) (2020)
Katherine J Carpenter, Aurore-Cecile Valfort, Nick Steinauer, Arindam Chatterjee, Suomia Abuirqeba, Shabnam Majidi, Monideepa Sengupta, Richard J Di Paolo, Laurie P Shornick, Jinsong Zhang, Colin A Flaveny
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer. Scientific reports 9 (1) (2019)
Ryan D Welch, Cyrielle Billon, Aurore-Cecile Valfort, Thomas P Burris, Colin A Flaveny
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle. Scientific reports 7 (1) (2017)

Colin A Flaveny.css-eqlu8i{font-size:small;padding-left:4px;}